≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Polymyositis

DOID EFO Endpoint Browser PheWeb

M13_POLYMYO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M33.2
  • Hospital discharge: ICD-9 — 7104
  • Hospital discharge: ICD-8 — 7161
  • Cause of death: ICD-10 — M33.2
  • Cause of death: ICD-9 — 7104
  • Cause of death: ICD-8 — 7161

2 out of 7 registries used, show all original rules.

296

4. Check minimum number of events

None

296

5. Include endpoints

None

296

6. Filter based on genotype QC (FinnGen only)

296

Control definitions (FinnGen only)

Control exclude
M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M33
Name in latin
Polymyositis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2237 1327 876
Only index persons 1502 917 585
Unadjusted period prevalence (%)
Whole population 0.03 0.04 0.02
Only index persons 0.03 0.03 0.02
Median age at first event (years)
Whole population 60.94 61.53 59.95
Only index persons 57.28 57.97 56.19

-FinnGen-

Key figures

All Female Male
Number of individuals 296 181 115
Unadjusted period prevalence (%) 0.06 0.06 0.05
Median age at first event (years) 55.49 55.05 56.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
271
Matched controls
2712
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.2
ICD-10 Finland
Polymyositis
+∞
316.4
238
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
23.1
97.4
156
150
M60.9
ICD-10 Finland
Myositis, unspecified
+∞
87.3
79
*
L04AX01
ATC
azathioprine; systemic
34.6
81.0
107
50
G72.9
ICD-10 Finland
Myopathy, unspecified
116.8
59.9
63
7
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
12.6
52.4
103
126
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
46.2
43
*
H02AB06
ATC
prednisolone; systemic
7.2
45.4
216
953
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
44.0
41
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.3
43.8
180
645
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.1
43.4
81
85
M05BA04
ATC
alendronic acid; oral
10.2
41.1
89
124
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
37.4
35
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
408.9
36.9
36
*
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
36.3
34
*
H02AB07
ATC
prednisone; oral
7.1
35.9
102
213
M60.8
ICD-10 Finland
Other myositis
395.7
35.8
35
*
P01BA02
ATC
hydroxychloroquine; oral
10.1
34.5
73
95
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
133.4
33.5
35
*
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
180.6
31.4
32
*
NXL00
NOMESCO Finland
Biopsy of muscle
90.5
29.5
32
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
12.7
25.3
46
43
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.4
23.1
53
76
L04AA06
ATC
mycophenolic acid; systemic
20.3
22.9
34
19
7104A
ICD-9 Finland
Diffuse diseases of connective tissue, Polymyositis
+∞
21.1
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
20.6
162
819
71610
ICD-8 Finland
Polymyositis and dermatomyositis, Polymyositis
+∞
20.0
19
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
107.6
18.8
20
*
L04AD01
ATC
ciclosporin; systemic
17.9
18.8
29
18
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
23.8
18.6
26
12
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
17.9
17
*
M35.1
ICD-10 Finland
Other overlap syndromes
192.0
17.7
18
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
19.5
16.8
25
14
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.7
16.5
39
58
L04AA01
ATC
[U] ciclosporin; systemic
14.9
16.4
27
20
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.3
16.0
44
81
M05BA07
ATC
risedronic acid; oral
7.8
13.5
31
44
L88
ICPC
Rheumatoid/seropositive arthritis
7.3
13.3
32
49
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
17.9
13.2
20
12
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
12.6
12
*
G72.8
ICD-10 Finland
Other specified myopathies
11.3
12.5
23
22
L19
ICPC
Muscle symptom/complaint NOS
15.6
12.0
19
13
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.8
11.7
22
22
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
11.6
92
423
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
11.5
11
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
11.3
49
146
C03CA01
ATC
furosemide; systemic
2.6
11.3
112
585
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.3
11.0
42
111
TGC00
NOMESCO Finland
Bronchial lavation
9.5
11.0
22
25
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
10.8
48
146
R13
ICD-10 Finland
Dysphagia
4.7
10.7
37
89
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
10.7
105
541
L28
ICPC
Limited function/disability (L)
3.0
10.3
65
257
ZX120
NOMESCO Finland
Intravenous
3.9
10.2
43
125
JN4BD
NOMESCO Finland
Extensive body CT
3.7
10.0
45
138
R06.0
ICD-10 Finland
Dyspnoea
2.6
10.0
88
423
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.7
9.8
33
77
R50.9
ICD-10 Finland
Fever, unspecified
3.1
9.5
56
210
A02BC02
ATC
pantoprazole; systemic
2.3
9.3
188
1348
L99
ICPC
Musculoskeletal disease other
8.2
9.3
20
26
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
9.3
35
92
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
9.3
42
130
C08CA05
ATC
nifedipine; systemic
4.6
9.1
31
74
H26.3
ICD-10 Finland
Drug-induced cataract
19.4
9.0
13
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
8.9
58
234
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
8.8
80
389
R4110
NOMESCO Finland
Physiotherapy
2.4
8.5
91
478
R4120
NOMESCO Finland
Occupational therapy
4.4
8.5
30
74
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
92.8
8.5
9
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
8.4
66
296
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
8.4
8
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
+∞
8.4
8
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
8.3
38
118
XG410
NOMESCO Finland
Flow-volume spirometry
5.6
8.2
23
44
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
13.6
8.0
13
10
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.3
7.9
28
70
R4190
NOMESCO Finland
Nutritional therapy
8.0
7.5
16
21
XG466
NOMESCO Finland
Sleep oxymetry
6.6
7.4
18
29
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.2
7.3
27
70
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
7.3
7
*
R1250
NOMESCO Finland
Evaluation of functional capability
7.7
7.3
16
22
H05AA02
ATC
teriparatide; parenteral
16.3
7.3
11
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
7.3
49
200
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.9
7.2
44
167
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
30.9
7.2
9
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
7.2
72
365
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.2
7.1
14
16
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.6
7.1
17
27
318
Kela drug reimbursment
Teriparatide
14.3
6.9
11
8
A28
ICPC
Limited function/disability NOS
2.6
6.8
50
215
XX9XE
NOMESCO Finland
Other ultrasound examination
17.2
6.8
10
6
AA1AD
NOMESCO Finland
CT of head and brain
2.3
6.8
73
380
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.3
6.8
33
109
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.8
6.7
18
33
J05AB01
ATC
aciclovir; systemic
2.3
6.7
71
366
EBA10
NOMESCO Finland
Surgical removal of tooth
3.0
6.7
38
139
N99
ICPC
Neurological disease other
12.7
6.6
11
9
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
6.5
34
118
G71.08
ICD-10 Finland
Other muscular dystrophy
71.5
6.5
7
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
71.5
6.5
7
*
XA402
NOMESCO Finland
ENMG
5.8
6.4
17
31
M79.1
ICD-10 Finland
Myalgia
2.7
6.3
43
176
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
18.5
6.3
9
5
M60.0
ICD-10 Finland
Infective myositis
+∞
6.3
6
*
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
6.3
6
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
6.5
6.3
15
24
N28
ICPC
Limited function/disability (N)
8.0
6.2
13
17
Z50.1
ICD-10 Finland
Other physical therapy
3.7
6.1
25
72

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
94
12
114.32
181.76
4.1
1.2
u/l
9.3
5.4
1.79
89
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
49
11
53.18
84.05
1.2
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
53
42
15.15
56.11
1.8
1.2
u/ml
51.3
—
—
8
0
(3037522) Nuclear Ab [Titer] in Serum
119
283
6.36
51.36
1.7
1.3
titre
680.9
375.6
1.57
47
64
(42870588) Differential panel, method unspecified - Blood
184
743
4.90
40.24
15.5
5.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
47
53
10.35
39.16
1.6
1.2
u/ml
3.6
3.1
—
18
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
64
9.20
37.80
2.1
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
219
1145
4.51
30.77
17.8
5.4
e9/l
0.0
0.0
0.82
211
985
(3001604) Monocytes [#/volume] in Blood
218
1139
4.47
30.59
17.7
5.4
e9/l
0.6
0.6
0.71
211
981
(3019198) Lymphocytes [#/volume] in Blood
219
1168
4.36
29.34
17.8
5.4
e9/l
1.7
2.0
1.30
213
1035
(3013115) Eosinophils [#/volume] in Blood
219
1183
4.27
28.43
18.2
5.8
e9/l
0.2
0.2
1.45
213
1042
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
41
59
7.91
27.89
1.5
1.6
—
0.0
—
0
7
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
23
18
13.77
23.99
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
18
13.77
23.99
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
23
18
13.77
23.99
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
19
13.04
23.23
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
19
13.04
23.23
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
23
19
13.04
23.23
1.3
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
226
1347
3.87
23.10
20.4
9.1
e9/l
4.4
4.1
0.97
218
1181
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
223
4.02
21.38
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
140
4.60
20.46
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
24
26
9.96
20.25
1.6
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
197
1149
3.14
19.36
14.2
6.6
mmol/l
1.2
1.2
0.60
174
976
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
187
1063
3.06
19.18
12.3
5.5
mmol/l
1.2
1.2
1.03
178
955
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
256
3.65
19.16
1.5
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
358
3.12
16.64
2.4
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
50
146
3.92
15.33
2.5
2.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
44
6.38
15.06
11.3
8.0
iu/ml
189.1
144.3
—
7
8
(3018418) pH of Serum or Plasma
136
720
2.64
14.86
6.0
3.9
ph
7.4
7.4
0.18
23
137
(3000494) Fungus identified in Specimen by Culture
74
284
3.14
14.84
2.2
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
16
16
10.51
14.14
1.4
1.2
u/ml
2.2
—
—
5
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
53
170
3.58
14.13
4.8
3.5
ng/l
189.2
191.3
0.02
47
159
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
55
5.52
13.93
1.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
146
822
2.53
13.76
5.5
3.7
e6/l
156.9
65.0
0.40
103
580
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
16
17
9.89
13.55
1.6
1.2
u/ml
133.7
—
—
6
0
(3013707) Erythrocyte sedimentation rate by Westergren method
243
1758
3.13
13.49
13.1
3.8
mm/h
15.6
12.2
3.02
237
1608
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
27
53
5.51
13.43
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
119
614
2.57
13.43
7.0
4.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
159
942
2.49
13.28
3.1
2.2
nmol/l
80.3
77.8
0.50
152
833
(3034770) Mitochondria Ab [Titer] in Serum
27
56
5.20
12.64
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
60
5.05
12.64
1.8
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
129
709
2.45
12.53
4.9
3.1
ng/l
1160.8
1192.6
0.04
118
605
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
254
3.00
12.48
2.3
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
166
3.34
11.93
2.4
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
222
1578
2.63
11.89
9.5
4.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
86
4.19
11.73
3.0
2.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
77
4.38
11.72
2.0
2.3
g/l
3.2
3.1
0.12
24
64
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
52
5.16
11.66
1.3
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
78
4.32
11.52
2.0
2.2
g/l
9.7
9.8
0.04
25
71
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
34
6.24
11.48
1.6
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
20
34
6.24
11.48
1.7
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
163
1024
2.32
11.33
7.5
4.2
g/l
33.9
35.6
2.85
158
964
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
84
4.15
11.26
1.9
2.2
g/l
3.3
3.8
1.99
23
62
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
84
4.15
11.26
1.9
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
84
4.15
11.26
1.9
2.2
g/l
7.3
7.4
0.06
25
66
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
28
6.78
11.22
2.3
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
464
2.46
10.91
2.1
1.4
g/l
2.1
2.5
0.72
70
272
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
20
36
5.89
10.85
1.3
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
34
5.90
10.36
1.3
1.2
u/ml
224.4
236.0
0.05
13
20
(40758558) Short blood count panel - Blood
111
611
2.31
10.34
14.2
6.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
31
6.12
10.19
1.4
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
251
2.74
10.03
2.3
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
112
633
2.24
9.67
4.7
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
170
1135
2.17
9.60
5.6
3.6
estimate
0.0
0.0
0.00
30
209
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
45
4.95
9.45
1.5
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
183
1264
2.17
9.39
9.0
6.2
umol/l
10.3
11.2
0.90
177
1188
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
17
7.95
9.35
1.1
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
127
764
2.16
9.31
6.0
3.0
u/l
49.4
31.6
1.97
122
726
(3015736) pH of Urine
140
880
2.12
9.10
4.8
3.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
113
656
2.17
9.01
4.6
3.0
e6/l
0.4
0.3
0.11
88
476
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
47
4.73
8.99
1.7
1.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
12
15
8.30
8.92
2.3
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
209
2.74
8.82
7.9
4.1
%
0.7
0.8
0.35
21
68
(3025159) Blasts/100 leukocytes in Blood
47
185
2.83
8.76
7.9
4.3
%
0.0
0.2
0.57
20
53
(3002582) Erythrocytes [#/volume] in Urine
119
711
2.13
8.76
4.6
3.1
e6/l
19.7
147.3
0.77
96
535
(44790047)
15
25
6.27
8.74
1.9
1.8
—
—
—
0
0
(44790048)
15
25
6.27
8.74
1.9
1.8
—
—
—
0
0
(44806118)
15
25
6.27
8.74
1.9
1.8
—
—
—
0
0
(44790049)
15
25
6.27
8.74
1.9
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
41
152
2.97
8.51
5.6
4.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
87
464
2.24
8.49
6.4
3.7
ng/l
210.3
195.5
0.04
79
375
(3021601) Nitrite [Presence] in Urine by Test strip
167
1143
2.06
8.42
7.7
4.9
estimate
0.0
0.0
0.00
34
210
(3000850) Epithelial cells [#/volume] in Urine
87
467
2.22
8.34
3.3
2.6
e6/l
3.4
4.6
0.84
76
414
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
9
15.03
8.28
1.9
2.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
57
256
2.52
8.18
17.8
6.9
kpa
5.3
5.1
0.65
52
244
(3027801) Oxygen [Partial pressure] in Arterial blood
57
256
2.52
8.18
17.7
6.9
kpa
10.4
12.2
2.44
52
246
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
14
8.12
8.04
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
167
1157
2.02
7.99
5.7
3.7
estimate
0.0
0.0
0.00
35
202
(4035726)
51
221
2.58
7.87
1.5
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
64
310
2.36
7.77
3.1
2.3
%
22.1
22.7
0.13
52
268
(3002179) Metamyelocytes/100 leukocytes in Blood
45
185
2.69
7.70
6.7
4.3
%
0.6
0.4
0.47
17
50
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
25
5.83
7.61
1.9
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
54
4.11
7.57
1.3
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
57
266
2.42
7.50
1.9
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
116
719
2.01
7.49
3.4
3.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
56
260
2.42
7.45
18.1
6.9
mmol/l
2.0
1.2
0.49
46
208
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
77
410
2.19
7.44
3.6
2.6
e6/l
0.7
1.2
1.56
46
233
(3021589) Normoblasts [#/volume] in Blood
152
1040
1.95
7.32
22.8
9.5
e9/l
0.0
0.0
0.15
137
844
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
26
5.60
7.32
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
67
342
2.24
7.16
3.3
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
23
5.87
7.13
1.8
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
39
4.56
7.05
1.6
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
43
181
2.61
7.01
19.3
7.1
mmol/l
11.1
9.7
0.44
43
174
(3021440) Promyelocytes/100 leukocytes in Blood
45
194
2.56
6.99
8.3
4.3
%
0.0
0.2
2.19
21
60
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
20
6.21
6.96
2.2
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
63
3.69
6.85
3.4
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
531
2.03
6.85
5.9
3.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
45
197
2.51
6.77
3.2
2.2
ug/l
18.3
7.2
2.02
39
174
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
37
4.51
6.57
1.1
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
33
4.73
6.53
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
55
268
2.29
6.53
2.5
2.6
umol/l
7.2
9.4
0.53
44
236
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
70
379
2.11
6.40
4.1
2.8
e6/l
2.7
2.7
0.00
41
205
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
15
6.86
6.35
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
10
15
6.86
6.35
1.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
34
4.59
6.31
1.1
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
97
597
1.93
6.18
4.1
2.7
umol/l
374.9
8984.9
3.30
91
510
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
86
509
1.97
6.14
1.2
1.2
u/ml
1.0
1.3
0.24
17
149
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
71
393
2.06
6.10
1.5
1.2
iu/ml
62.8
41.7
0.35
27
125
(3032080) INR in Blood by Coagulation assay
138
959
1.82
5.96
12.4
8.0
inr
1.3
1.2
0.53
37
289
(3000991) Gas panel - Venous blood
40
178
2.44
5.80
25.6
7.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
28
4.81
5.79
1.4
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
37
4.22
5.70
1.9
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
33
4.40
5.62
1.9
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
47
3.78
5.57
4.0
5.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
21
5.40
5.57
1.1
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
38
4.10
5.51
1.7
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
18
5.71
5.36
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
44
3.79
5.28
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
44
3.79
5.28
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
75
448
1.90
5.12
3.7
2.8
mosm/kgh2o
551.9
543.9
0.11
65
379
(46235355) HIV 1 and 2 tests - Meaningful Use set
58
318
2.02
5.06
1.6
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
36
4.03
5.04
5.2
2.8
e9/l
5.2
4.9
0.16
14
36
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
31
131
2.53
5.01
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
82
508
1.85
4.99
8.9
5.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
84
525
1.84
4.96
2.3
1.7
mg/l
1.3
1.2
0.16
67
422
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
37
3.92
4.87
5.6
3.4
%
65.7
61.1
0.70
14
37
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
79
2.93
4.83
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
24
4.72
4.82
1.5
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
86
546
1.81
4.81
2.7
2.0
mg/l
3.0
3.2
0.39
76
471
(42529406) Shigella sp [Presence] in Stool by Culture
22
80
2.89
4.73
1.5
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
80
2.89
4.73
1.4
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
44
223
2.14
4.71
2.3
2.3
u/l
518.7
33.0
0.49
37
187
(40768443) Skin Pathology biopsy report
27
110
2.60
4.70
1.1
1.3
—
—
—
0
0
(4306422)
12
29
4.27
4.67
1.3
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
7
5
14.29
4.59
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
5
14.29
4.59
1.0
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
176
1376
1.69
4.57
11.2
4.4
mmol/l
6.5
6.7
1.23
166
1283
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.89
4.56
1.5
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
21
4.89
4.56
1.5
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
21
4.89
4.56
1.5
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
8
10.23
4.54
1.4
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
108
746
1.70
4.46
2.9
2.4
u/l
53.8
55.0
0.17
102
680
(3022313) Gas panel - Capillary blood
26
107
2.57
4.44
5.3
3.5
—
—
—
0
0
(3004451) EKG impression Narrative
9
12
7.69
4.38
1.7
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
115
815
1.67
4.28
4.1
3.3
mmol/l
2.3
2.4
1.12
104
712
(3019309) Folate [Moles/volume] in Red Blood Cells
71
441
1.80
4.22
1.7
1.7
nmol/l
1151.8
1180.3
0.09
56
326
(3048689) Calprotectin [Mass/mass] in Stool
48
263
1.98
4.18
2.0
2.2
ug/g
163.8
143.3
0.19
39
203
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
131
967
1.64
4.12
2.1
2.0
pmol/l
95.8
95.0
0.06
73
479
(3021960) Folate [Moles/volume] in Serum or Plasma
87
578
1.72
4.09
1.6
1.5
nmol/l
20.5
21.6
0.33
76
484
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
70
2.83
4.00
1.7
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
113
2.43
3.98
33.6
8.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
33
3.75
3.96
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
38
3.53
3.95
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
378
1.81
3.90
1.3
1.2
u/ml
53.0
11.3
0.68
18
145
(3001122) Ferritin [Mass/volume] in Serum or Plasma
129
959
1.61
3.88
3.4
2.6
ug/l
165.9
114.5
1.17
121
882
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
121
2.36
3.87
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
135
2.27
3.82
2.1
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
5
12.21
3.78
1.2
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
50
3.11
3.74
3.9
3.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
35
3.53
3.66
3.0
2.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
86
2.55
3.64
2.8
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
51
3.04
3.63
2.8
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
63
2.80
3.55
5.5
2.1
u/ml
0.3
0.3
—
10
29
(4027681)
9
17
5.42
3.53
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
13
6.29
3.52
1.8
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
156
2.10
3.39
4.2
2.5
e9/l
4.0
4.0
0.01
26
122
(3022806) Fractional oxyhemoglobin in Capillary blood
10
27
3.80
3.38
3.8
1.9
%
90.4
90.0
—
10
27
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
10
7.14
3.38
1.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
124
938
1.55
3.34
5.4
3.6
ng/l
91.1
31.5
3.13
102
658
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
54
2.87
3.30
2.1
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
195
1.96
3.24
2.9
3.0
e9/l
60.3
71.8
1.00
24
149
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
44
3.04
3.17
1.4
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
20
87
2.39
3.08
1.1
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
16
5.11
3.07
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
16
5.11
3.07
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
40
229
1.86
3.06
2.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
57
2.72
3.01
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
40
3.08
3.00
1.7
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
5
10.14
2.99
1.0
1.2
—
—
—
0
0
(3010421) pH of Blood
15
58
2.67
2.92
9.0
3.1
ph
7.4
7.4
0.32
15
50
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
22
4.19
2.90
1.8
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
9
6.78
2.88
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
9
6.78
2.88
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
69
470
1.61
2.86
2.4
2.9
mmol/l
2.5
2.5
0.13
58
415
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
124
2.11
2.86
2.3
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
48
300
1.72
2.76
24.5
21.0
inr
2.2
1.3
—
5
38
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
10
6.10
2.71
1.8
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
10
6.10
2.71
1.8
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
10
6.10
2.71
1.8
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.7
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
15
4.75
2.61
2.1
2.9
u/ml
972.4
739.6
—
7
15
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.7
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.7
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
11
5.54
2.55
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
38
229
1.76
2.48
6.9
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
256
2343
1.69
2.46
35.6
13.4
mg/l
20.2
23.6
1.37
244
1831
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
34
3.01
2.43
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
201
2241
0.68
2.41
4.7
4.1
mmol/l
1.7
1.3
3.74
189
2043
(3020891) Body temperature
18
85
2.19
2.34
4.6
4.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
28
3.28
2.32
5.0
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
53
2.52
2.31
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
79
2.22
2.29
2.6
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
23
3.54
2.28
1.1
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
18
3.96
2.26
3.6
2.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.63
2.22
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
179
1540
1.41
2.18
4.2
3.0
u/l
51.3
49.2
0.17
173
1428
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
30
3.06
2.16
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
19
3.75
2.16
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
14
4.35
2.16
1.3
1.5
g/l
1.0
1.0
—
6
14
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
14
4.35
2.16
1.5
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
68
2.27
2.15
1.2
1.4
ug/g
324.9
252.5
—
9
37
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
212
2325
0.69
2.11
5.0
4.5
mmol/l
1.3
1.5
6.34
201
2140
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
20
3.56
2.06
1.0
1.1
—
—
—
0
0
(4062490)
7
20
3.56
2.06
1.4
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
20
3.56
2.06
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
171
1.77
2.06
1.2
1.2
—
—
—
0
0
(4268621)
8
26
3.13
2.03
1.9
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
83
631
1.44
2.02
4.6
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
57
2.34
2.00
1.3
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
62
830
0.68
1.96
2.7
3.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
71
2.17
1.96
2.7
3.1
g/l
0.4
0.2
—
5
23
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
11
4.60
1.95
1.2
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
11
4.60
1.95
4.2
2.0
ug/l
48.2
59.2
—
5
11
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
22
3.23
1.89
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
67
495
1.46
1.89
7.1
3.9
kg/l
1.0
1.0
0.26
12
72
(40767503) Oxygen content in Capillary blood by calculation
11
46
2.45
1.87
4.5
2.6
%
15.2
16.5
—
5
23
(3042631) Mycobacterium sp identified in Specimen
10
40
2.55
1.85
1.9
3.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
17
3.58
1.84
1.3
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
60
2.22
1.80
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
29
2.81
1.80
1.1
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
14
67
2.14
1.79
11.5
6.6
mmol/l
1.2
1.3
—
9
58
(3006184) Hemoglobin [Mass/volume] in Capillary blood
12
54
2.27
1.76
3.3
2.1
g/l
114.0
132.1
—
7
37
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
18
3.38
1.75
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
36
2.55
1.75
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
216
2339
0.72
1.71
5.0
4.6
mmol/l
4.8
4.7
0.64
204
2162
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
189
0.46
1.68
2.1
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
19
3.20
1.67
2.7
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
49
2.29
1.65
1.1
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
106
1.85
1.63
2.2
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
37
249
1.56
1.62
6.2
3.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
20
3.04
1.59
1.5
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
138
1.72
1.57
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
198
1781
1.34
1.55
4.7
4.0
pmol/l
15.2
14.8
1.68
185
1600
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
33
2.46
1.55
1.4
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
28
179
1.62
1.52
7.1
2.6
kpa
4.8
4.4
0.67
28
172
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.16
1.44
1.2
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
16
3.16
1.44
1.2
1.5
—
—
—
0
0
(4010399)
29
190
1.58
1.44
2.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
45
326
1.45
1.41
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
23
2.64
1.37
2.8
2.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
42
2.18
1.35
15.2
1.8
%
68.8
59.2
—
9
42
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
223
2378
0.75
1.31
5.4
5.2
mmol/l
2.9
2.8
1.10
213
2183
(3032773) Endomysium IgG Ab [Titer] in Serum
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
713
1.31
1.29
3.2
3.1
mmol/l
6.5
7.3
1.02
75
592
(3024928) Oxygen saturation in Venous blood
10
48
2.12
1.29
14.7
2.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
18
2.81
1.29
3.2
2.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
25
2.43
1.25
2.2
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
25
2.43
1.25
2.2
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
83
679
1.31
1.25
3.2
3.2
mg/l
3810.8
151.4
1.55
60
432
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.66
1.22
1.2
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
106
899
1.28
1.21
6.2
3.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
77
626
1.31
1.21
7.2
3.8
estimate
0.0
0.0
0.00
34
206
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
2.2
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
26
2.33
1.19
2.2
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
2.2
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
2.2
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
57
1.97
1.18
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
20
2.52
1.15
1.6
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
30
2.36
1.13
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
112
1.65
1.11
1.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
66
1.85
1.10
2.3
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
124
1085
1.25
1.06
5.6
3.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
46
1.99
1.04
1.9
1.3
—
—
—
0
0
(4146454)
5
22
2.29
1.04
1.0
3.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
49
1.86
0.99
1.8
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
27
2.25
0.94
4.3
3.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
27
2.25
0.94
1.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
126
0.54
0.90
1.7
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
29
2.09
0.90
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
86
735
1.24
0.90
3.2
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
40
310
1.34
0.88
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
164
0.60
0.83
1.6
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
10
58
1.75
0.80
4.1
2.3
kpa
8.5
7.9
—
10
50
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
65
549
1.24
0.75
3.2
2.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
24
2.10
0.75
1.4
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
125
1.47
0.74
1.2
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
194
0.65
0.74
1.2
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
25
2.02
0.73
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
26
1.94
0.71
1.0
1.3
nmol/l
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
277
1.30
0.69
1.4
1.7
%
1.4
1.5
0.72
28
240
(3020682) Albumin/Creatinine [Ratio] in Urine
83
726
1.20
0.69
3.9
4.0
mg/mmol
9.9
8.9
0.09
51
454
(40768795) Lymph node Pathology biopsy report
5
28
1.80
0.66
1.4
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
26
199
1.34
0.65
7.0
2.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
204
1.30
0.56
3.0
2.9
ml/min/173m2
82.4
62.5
—
8
83
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
37
1.63
0.56
2.2
2.7
—
9.9
—
0
8
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
169
1.33
0.55
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
60
1.52
0.55
1.7
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
224
2151
1.17
0.53
5.7
4.8
mu/l
1.9
2.5
0.50
215
1937
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
63
1.44
0.53
3.8
2.3
mmol/l
24.5
24.9
—
9
52
(40768804) Tissue Pathology biopsy report
106
967
1.15
0.52
2.7
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
34
282
1.23
0.49
1.5
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
651
1.16
0.49
1.6
1.6
mmol/l
1.7
1.3
2.17
65
552
(3021901) Oxygen saturation in Capillary blood
7
46
1.53
0.48
4.6
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
215
2230
0.87
0.47
6.4
5.8
mmol/mol
40.1
40.0
0.08
204
2064
(40768793) Breast Pathology biopsy report
5
81
0.61
0.46
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
50
1.41
0.45
1.6
1.2
u/l
13.9
9.8
—
7
38
(3003327) Ova and parasites identified in Stool by Light microscopy
10
69
1.46
0.45
1.7
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
130
0.68
0.44
2.4
4.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
57
1.41
0.42
1.8
1.8
—
—
—
0
0
(3013512) EKG study
80
726
1.14
0.42
4.1
3.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
353
1.19
0.42
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
33
1.52
0.41
1.4
2.0
pg
32.2
32.0
—
5
33
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
16
0.00
0.41
0.0
3.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
6.5
—
0
5
(3044889) 12 lead EKG panel
177
1691
1.12
0.39
5.9
3.9
—
—
—
0
0
(1002224) Polysomnography panel
14
107
1.32
0.38
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
41
1.47
0.36
4.8
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
45
1.34
0.34
7.5
2.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
191
1978
0.90
0.33
44.2
17.8
g/l
329.1
332.3
4.81
191
1969
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
240
1.18
0.31
1.5
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
96
0.72
0.31
1.6
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
45
402
1.14
0.31
2.8
3.0
ug/l
0.7
0.8
0.36
33
264
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
182
0.81
0.27
1.4
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
188
1.18
0.26
6.0
4.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
76
1.19
0.25
1.4
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
104
0.76
0.21
3.1
3.4
u/ml
10.3
1467.8
—
8
89
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
29.7
—
1465.2
—
0
13
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
14.6
—
837.7
—
0
13
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
48
1.26
0.20
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
14
0.00
0.20
0.0
17.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
146
1.17
0.20
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
227
2306
0.93
0.16
5.2
4.6
mmol/l
5.8
6.0
1.71
208
2117
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
140
1359
1.06
0.16
3.1
2.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
8
72
1.11
0.16
4.6
4.1
mmol/l
3.9
4.0
—
8
63
(3009542) Hematocrit [Volume Fraction] of Blood
207
2104
0.95
0.14
41.8
14.6
%
39.6
39.8
0.08
141
1503
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
355
0.92
0.13
2.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
308
1.08
0.12
4.5
4.3
%
28.1
31.7
1.24
25
190
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
71
683
1.05
0.11
4.7
4.7
ug/l
4.0
2.2
0.56
65
612
(3022621) pH of Urine by Test strip
14
155
0.90
0.09
2.9
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
247
2449
1.05
0.09
28.0
12.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.0
1.7
—
—
—
0
0
(4034850)
7
85
0.82
0.07
35.3
10.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
292
1.03
0.02
7.6
6.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
547
0.98
0.01
3.6
4.3
%
21.4
21.4
0.02
26
256
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
224
2234
1.01
0.00
28.2
13.0
ml/min/173m2
86.5
79.9
3.55
203
1824
(3017446) Testosterone [Moles/volume] in Serum or Plasma
15
148
1.01
0.00
2.1
2.4
nmol/l
11.2
13.9
1.11
15
137
(3003694) ABO and Rh group [Type] in Blood
59
593
0.99
0.00
1.4
1.4
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.7
—
4.4
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
30.4
—
0
9
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.0
—
86.0
—
0
5
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.2
—
0
6
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.0
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
56
0.89
0.00
2.6
2.3
—
—
—
0
0
(44813793)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.0
—
0
5
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
2.0
—
1.6
—
0
8
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
-0.00
0.0
1.9
—
1.2
—
0
8

Mortality – FinRegistry

↥

Association

Association between endpoint M13_POLYMYO and mortality.

Females

Parameter HR [95% CI] p-value
M13_POLYMYO 2.097 [1.76, 2.5] < 0.001
Birth year 0.994 [0.99, 1.0] 0.186

During the follow-up period (1.1.1998 — 31.12.2019), 247 out of 750 females with M13_POLYMYO died.

Males

Parameter HR [95% CI] p-value
M13_POLYMYO 2.472 [2.02, 3.03] < 0.001
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 217 out of 521 males with M13_POLYMYO died.

Mortality risk

Mortality risk for people of age

years, who have M13_POLYMYO.

N-year risk Females Males
1 0.119% 0.47%
5 1.131% 2.714%
10 2.947% 6.901%
15 5.887% 13.095%
20 10.067% 21.454%

Relationships between endpoints

↥

Index endpoint: M13_POLYMYO – Polymyositis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data